Hull medical tech firm’s reflux device set for US launch
Hull-based medical tech company RD Biomed has officially registered a device for the non-invasive diagnosis of reflux disease with the US Food and Drug Administration (FDA) ahead of its launch in the country this year.
Peptest is a non‑invasive, diagnostic medical device that contains antibodies for detecting the stomach enzyme pepsin in clinical samples, such as saliva or sputum.
Peptest was created by renowned gastrointestinal specialist Professor Peter Dettmar, director of Hull-based RD Biomed and the former global research... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
